The peptide side effects research overview covers the broader safety framework relevant to GH-axis research protocols
"FDA proposes to exclude semaglutide, tirzepatide, and liraglutide from 503B bulks list." 2026
Challet E
Baseline laboratory investigations are recommended to assess liver function, kidney function, oxidative stress markers, and nutritional deficiencies prior to initiating therapy
Date July 25, 2025 Proper name(s), Common name(s), Source information References: Proper name: RSC 2024
Quick Comparison Mechanism Differences That Matter HGH (Somatropin) HGH increases circulating IGF-1 and affects: Lipolysis and body composition Connective tissue remodeling Recovery and sleep architecture in some users Broader endocrine adaptation over time Because HGH is upstream, effects can be more systemic and slower to stabilize